Boston Scientific sets dates for investor conference and Q3 earnings
Boston Scientific executives are heading to the Wells Fargo 21st Annual Healthcare Conference this September, marking the start of a busy autumn for the medical device giant. The appearance precedes the company’s scheduled third-quarter financial report, which will detail performance for the period ending September 30.
Chairman and CEO Mike Mahoney will be joined by Senior Vice President and Global Chief Medical Officer Dr. Kenneth Stein at the Wells Fargo event on September 10. The pair is slated for a 35-minute question-and-answer session beginning at 8:00 a.m. ET. Investors looking for a deeper dive into the company’s financials should mark their calendars for October 28.
On that date, Mahoney and CFO Jon Monson will host a webcast at 8:00 a.m. ET to unpack the third-quarter results. The company plans to release its formal earnings statement shortly before the call begins. Both the conference appearance and the earnings webcast will be available for public viewing and later replay through the Boston Scientific investor relations website.
Comments (0)
No comments yet. Be the first!